Close

Barclays Maintains an 'Overweight' on ZIOPHARM Oncology (ZIOP); 4Q10 Results and Model Update Mar 2, 2011 01:47PM
UPDATE - Barclays Initiates coverage on ZIOPHARM Oncology (ZIOP) with an Overweight; Attractively Valued - Palifosfamide Key Driver Feb 23, 2011 12:42PM
Notable Analyst Rating Changes 02/23: (AMAT) (AKS) (YOKU) (HOC) Upgraded; (NFLX) (FRX) (MDT) (MRO) Downgraded Feb 23, 2011 10:49AM
Barclays Starts ZIOPHARM Oncology (ZIOP) at Overweight Feb 23, 2011 08:10AM
ZIOPHARM Oncology (ZIOP) To Offer 9.6M Shares Feb 2, 2011 04:18PM